|
|
||||||||
The Journal of Immunology, Vol 156, Issue 10 3737-3746, Copyright © 1996 by American Association of Immunologists
ARTICLES |
G Ruggiero, EM Caceres, A Voordouw, E Noteboom, D Graf, RA Kroczek and H Spits
Division of Immunology of the Netherlands Cancer Institute, Amsterdam.
Human thymic epithelial cells express CD40, so we examined the possible role of CD40 in activation of thymocytes. We observed that both CD4+CD8- and CD4-CD8+ thymocytes proliferate after stimulation by anti-CD3 mAb in the presence of cultured thymic epithelial cells. Costimulation of CD4+ thymocytes by thymic epithelial cells is partly inhibited by an anti-CD40 mAb, but this mAb has no effect on costimulation of CD8+ thymocytes. The selective costimulatory ability of CD40 for CD4+ thymocytes was confirmed in experiments in which thymocytes were stimulated with anti-CD3 in the presence of murine P815 cells transfected with CD40 cDNA. The level of costimulation induced by P815- CD40 was comparable with that induced by P815 cells expressing CD80 (B7.1). Treatment of thymocytes with the Ca2+ ionophore ionomycin and the phorbol ester PMA or with anti-CD3 mAb resulted in up-regulation of the CD40 ligand, suggesting that this molecule is involved in CD40- mediated costimulation of human thymocytes. Costimulation of thymocytes by CD80 strongly increased anti-CD3-induced death of fetal thymocytes. In contrast, costimulation by CD40 did not increase anti-CD3-mediated apoptosis of these thymocytes. To confirm that CD40 does not affect anti-CD3-induced cell death, we established a variant of the Jurkat T leukemic cell line that constitutively expresses CD40L and analyzed the sensitivity of this cell line for activation-induced apoptosis. In contrast to CD80, CD40 failed to increase anti-CD3-mediated apoptosis in CD40L+ Jurkat cells, whereas both CD40 and CD80 strongly increased IL-2 production induced by anti-CD3. These findings suggest that costimulation by CD40 is involved in clonal expansion of CD4+ thymocytes but not in activation-induced cell death.
This article has been cited by other articles:
![]() |
P. J. Spence and E. A. Green Foxp3+ regulatory T cells promiscuously accept thymic signals critical for their development PNAS, January 22, 2008; 105(3): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Terrazzano, M. Sica, C. Becchimanzi, S. Costantini, B. Rotoli, S. Zappacosta, F. Alfinito, and G. Ruggiero T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway J. Leukoc. Biol., July 1, 2005; 78(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ruggiero, G. Terrazzano, C. Becchimanzi, M. Sica, C. Andretta, A. M. Masci, L. Racioppi, B. Rotoli, S. Zappacosta, and F. Alfinito GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation J. Leukoc. Biol., September 1, 2004; 76(3): 634 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
N J Gallagher, A G Eliopoulos, A Agathangelo, J Oates, J Crocker, and L S Young CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion Mol. Pathol., April 1, 2002; 55(2): 110 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ghia, P. Transidico, J. P. Veiga, C. Schaniel, F. Sallusto, K. Matsushima, S. E. Sallan, A. G. Rolink, A. Mantovani, L. M. Nadler, et al. Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells Blood, August 1, 2001; 98(3): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pirozzi, V. Lombari, D. Zanzi, F. Ionna, M. L. Lombardi, S. Errico, G. Ruggiero, and C. Manzo CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth Int. Immunol., June 1, 2000; 12(6): 787 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, T. Town, D. Paris, T. Mori, Z. Suo, F. Crawford, M. P. Mattson, R. A. Flavell, and M. Mullan Microglial Activation Resulting from CD40-CD40L Interaction After -Amyloid Stimulation Science, December 17, 1999; 286(5448): 2352 - 2355. [Abstract] [Full Text] |
||||
![]() |
R. Chiarle, A. Podda, G. Prolla, E. R. Podack, G. J. Thorbecke, and G. Inghirami CD30 Overexpression Enhances Negative Selection in the Thymus and Mediates Programmed Cell Death Via a Bcl-2-Sensitive Pathway J. Immunol., July 1, 1999; 163(1): 194 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi CD38 is functionally dependent on the TCR/CD3 complex in human T cells FASEB J, May 1, 1998; 12(7): 581 - 592. [Abstract] [Full Text] |
||||
![]() |
U. Schonbeck, F. Mach, J.-Y. Bonnefoy, H. Loppnow, H.-D. Flad, and P. Libby Ligation of CD40 Activates Interleukin 1beta -converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1beta J. Biol. Chem., August 1, 1997; 272(31): 19569 - 19574. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A New Mechanism of NK Cell Cytotoxicity Activation: The CD40-CD40 Ligand Interaction J. Exp. Med., June 16, 1997; 185(12): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |